Health Care & Life Sciences » Biotechnology | ZIOPHARM Oncology Inc.

ZIOPHARM Oncology Inc.

ZIOPHARM Oncology Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
142.38 M
Public Float
130.44 M
ZIOPHARM Oncology Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.42
Market Cap
$954.88 M
Shares Outstanding
162.39 M
Public Float
153.95 M

Profile

Address
Parris Building
Boston Massachusetts 02129
United States
Employees -
Website http://www.ziopharm.com
Updated 07/08/2019
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Financials

View All

Scott L. Tarriff
Director
Randal J. Kirk
Director